Evidence of Altered Polyamine Concentrations in Cerebral Cortex of Suicide Completers

• Published in: Neuropsychopharmacology (New York, N.Y.) Vol. 35; no. 7; pp. 1477 - 1484
• Main Authors: GANG CHEN, Gary, FIORI, Laura M, MOQUIN, Luc, GRATTON, Alain, MAMER, Orval, MECHAWAR, Naguib, TURECKI, Gustavo
• Format: Journal Article
• Language: English
• Published: Basingstoke Nature Publishing Group 01.06.2010
• Subjects: Adult; Adult and adolescent clinical studies; Analysis of Variance; Biological and medical sciences; Brain; Cerebral Cortex - metabolism; Chromatography; Gas Chromatography-Mass Spectrometry - methods; Humans; Male; Mass spectrometry; Medical sciences; Mental depression; Mental disorders; Mental health; Middle Aged; Original; Polyamines; Postmortem Changes; Psychiatric Status Rating Scales; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Putrescine - metabolism; Scientific imaging; Spermidine - metabolism; Suicide; Suicides & suicide attempts; Canada; Montreal Quebec Canada; Quebec Canada; Gas chromatography; Cerebral cortex; Polyamine; gas chromatography-mass spectrometry; Spermidine; Central nervous system; Putrescine; Suicide; Mass spectrometry; polyamines; putrescine-D4; Encephalon
• ISSN: 0893-133X; 1740-634X
• DOI: 10.1038/npp.2010.17

Recent studies have implicated alterations in the expression of polyamine-related genes in the brains of suicide completers including widespread downregulation of spermidine/spermine N1-acetyltransferase, the key enzyme in polyamine catabolism, suggesting compensatory mechanisms attempting to increase brain levels of polyamines. Given the complexity of the polyamine system, quantification of the levels of the polyamines is an essential step in understanding the downstream effects of dysregulated gene expression. We developed a method using high-resolution capillary gas chromatography (GC) in combination with mass spectrometry (MS) for quantitation of polyamines from post-mortem brain tissue, which allowed us to accurately measure spermidine and putrescine concentrations in post-mortem brain tissues. Using this method, we analyzed putrescine and spermidine levels in a total of 126 samples from Brodmann areas 4, 8/9, and 11, from 42 subjects, comprising 16 suicide completers with major depression, 13 non-depressed suicide completers, and 13 control subjects. Both putrescine and spermidine levels fell within the expected nanomolar ranges and were significantly elevated in the brain of suicide completers with a history of major depression as compared with controls. These results were not accounted by possible confounders. This is the first GC-MS study to analyze the expression of putrescine and spermidine from post-mortem brain tissue and confirms the hypothesis raised by previous studies indicating alterations in putrescine and spermidine levels in suicide/major depression.